MedPath

Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis Pigmentosa

Completed
Conditions
Retinitis Pigmentosa
Registration Number
NCT06368375
Lead Sponsor
University Hospital Tuebingen
Brief Summary

Retrospective chart review study to elucidate the genotype and phenotype of patients with PRPF31-associated retinitis pigmentosa and asymptomatic carriers of the respective variant(s)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
87
Inclusion Criteria
  • genetically confirmed PRPF31-associated inherited retinal dystrophy or asymptomatic carrier of the respective variant(s)
Exclusion Criteria
  • none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fundus Photography (FP)September 2007 - January 2022

characterization of the retina with fundus photography

OptosSeptember 2007 - January 2022

characterization of the retina with ultra-wide-field scanning laser ophthalmoscopy

Best Corrected Visual Acuity (BCVA)September 2007 - January 2022

best corrected visual acuity

Autofluorescence (AF)September 2007 - January 2022

characterization of the retina with fundus autofluorescence

Optical Coherence Tomography (OCT)September 2007 - January 2022

characterization of the retina with optical coherence tomography, e.g. foveal ellipsoid zone loss

Full-Field Electroretinogram (ff-ERG)September 2007 - January 2022

characterization of retinal function with full-field electroretinogram

Visual Field (VF)September 2007 - January 2022

visual field as measured by semi-automated 90° kinetic visual field exam using target III4e

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Tuebingen

🇩🇪

Tuebingen, Baden-Wuerttemberg, Germany

© Copyright 2025. All Rights Reserved by MedPath